FTY720 has also been reported to have selective cytotoxicity against human cancer cell lines including multiple myeloma, 10) prostate cancer, 11) bladder cancer, 12) hepatoma, 13) breast cancer 14) and leukemia cells. 15) The cells incubated with FTY720 demonstrated features characteristic of apoptosis. However, the association between the phosphorylation of FTY720 and its cytotoxicity against cancer cells is not clear. Thus, we tested the effect of the phosphorylation of FTY720 and its related compounds ( Fig. 1 ) on the proliferation of human breast cancer cell lines (MCF-7, MDA-MB-231 and Sk-Br-3) and human colon cancer cell lines (HCT-116 and SW620). We also examined the influence of endogenous sphingosine kinases on the cytotoxicity of FTY720 using N,N-dimetylsphingosine (DMS), 16) an inhibitor of sphingosine kinase. Furthermore, we examined the influences of FTY720 and sphingosine on the activation of stress activated mitogen-activated protein kinases (MAPKs), c-Jun NH 2 -terminal kinase (JNK) and p38, as well as a survival MAPK, extracellular signal-regulated kinase (ERK), in MCF-7 cells.
MATERIALS AND METHODS
General Procedure IR spectra were recorded on Shimadzu FTIR-8400 infrared spectrophotometer. FAB-MS spectra were measured on a JEOL JMS-HX 100 instrument. Electrospray ionization mass spectra (ESI-MS) were measured on an API-3000 mass spectrometer (Applied Biosystems) fitted with a Turboionspray TM interface. 1 H-NMR spectra were recorded on JEOL EX-400 (400 MHz) instruments using tetramethylsilane as an internal standard. Analytical TLC and preparative TLC were performed using Silica gel 60 F254 (Merck, 0.25 and 0.5 mm, respectively) glass plates. Column chromatography was performed using Silica Gel 60 (70-230 mesh ASTM). All extracted solvents were dried over Na 2 SO 4 , followed by evaporation in vacuo.
Materials and Chemicals Sphingosine and DMS were purchased from Wako Pure Chemical Industries, Ltd. (Osaka, Japan) and sphingosine-1-P was obtained from the Kanto Chemical Co., Inc. (Tokyo, Japan). ISP-I-55 was prepared previously by one of our co-workers (T. Fujita).
17) FTY720
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was synthesized according to a method previously detailed. 18, 19) FTY720-P 20) and cFTY720-P 21) were synthesized starting from FTY720, as shown in Fig. 2 . The spectroscopic data were identical to that reported previously. Precise synthetic methods for the preparation of FTY720-P, cFTY720-P and the intermediates are described hereafter.
{2-Methyl-4-[2-(4-octylphenyl)ethyl]-4,5-dihydro-1,3-oxazol-4-yl}methanol (1)

20)
A solution of FTY720 (1.30 g, 4.2 mmol), N,NЈ-diisopropylethylamine (1.09 ml, 6.3 mmol) and triethyl orthoacetate (0.93 ml, 5.1 mmol) in DMF (10 ml) was stirred at 120°C for 2 h. The solution was extracted with EtOAc, washed with sat. NaCl and dried. Concentration and subsequent SiO 2 column chromatography (chloroform/methanolϭ9/1) gave 1 (1.20 g, 86%) as a colorless oil. 1 A solution of 2 (16.5 mg, 0.028 mmol) in methanol/acetic acidϭ1/1 (4.0 ml) was stirred over 10% palladium-on-charcoal (16 mg) under H 2 atmosphere for 7 h at rt. After removal of the catalyst by filtration, the filtrate was concentrated. The residue was dissolved in conc HCl/ethanolϭ1/10 (0.18 ml) and the solution was stirred at 50°C for 6 h. 0.47 ml of water was added and stirred at room temperature (rt) for over night to form a precipitate of HCl · FTY-720-P. The precipitate was collected by filtration, washed with EtOAc. The compound (8.3 mg, 76%) was used for the biological tests without further purification. 
Benzyl 2-Hydroxy-5-[2-(4-octylphenyl)ethyl]-2-oxido-1,3,2-dioxaphosphinan-5-ylcarbamate (5)
A solution of 2-nitrobenzaldoxime (39.7 mg, 0.24 mmol), 1,1,3,3-tetramethylguanidine (59.7 ml, 0.48 mmol) in dioxane (0.5 ml) was added to a solution of 4 (69.6 mg, 0.12 mmol) in dioxane (0.6 ml) and stirred for 44 h at rt. After removal of the solvent by evaporation, the residue was dissolved in methanol and treated with SEPHADEX IR-120 ion exchange resins. Concentration and subsequent separation with preparative SiO 2 TLC (CHCl 3 /methanolϭ7/3) gave 5 (43 mg, 75%) as a colorless oil. 1 A solution of 5 (45.8 mg, 0.091 mmol) in ethanol (5 ml) was stirred under H 2 atmosphere on 10% palladium-on-charcoal (4.5 mg) for 21 h at rt. After removal of the catalyst by filtration, the filtrate was concentrated to afford cFTY720-P (28.9 mg, 86%) as a colorless oil. 1 In Vitro Proliferation Assay Cells were seeded onto 96-well plates at the densities of 3000 cells/well. After 24 h of pre-cultivation, appropriate concentrations of the samples were added and the cells were cultured for 2 d. The relative growth ratio was determined by WST-1 assay using a cell counting kit (Dojindo Laboratories, Kumamoto, Japan) according to the manufacturer's instructions. The IC 50 value was determined from the dose response curve. At least three independent experiments were performed. The proliferation assay that tested the effects of DMS was performed using identical methods. Compounds with or without DMS were added to the wells and the plates were incubated for 78 h at 37°C in a humidified atmosphere containing 5% CO 2 before the WST-1 assay was conducted.
Western Blot MCF-7 cells on a 60-mm plate were cultivated for 24 h in a serum-free medium prior to the addition of the test compounds. The cells were incubated with FTY720 (10 mM) or sphingosine (20 mM) in a PRMI-1640 medium. After 0.5, 2, 4, 8, 12, or 24 h the medium was removed and the cells were washed twice with PBS. The cells were lysed and protein extraction was performed. The components of the lysis buffer were as follows: 1% Nonidet P-40 (Roche Diagnostics GmbH, Penzberg, Germany), 0.1% SDS, 0.05% sodium deoxycholate, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 100 mM NaCl, 20 mM sodium pyrophosphate, 2 mM sodium orthovanadate, 1 mM NaF, 1.2 mg aprotinin, 0.2 mg leupeptin, 0.02 mg pepstatin, and 1 mM PMSF in 10 mM Tris-HCl (pH 8.0). The samples were separated by SDS-PAGE (Daiichi Pure Chemicals Co., Ltd., Tokyo, Japan) electrophoretically transferred to a polyvinylidene difluoride membrane (Pall Co., East Hills, NY, U.S.A.) and labeled with rabbit polyclonal anti-ERK, anti-phospho-ERK, anti-JNK, anti-phospho-JNK, anti-p38, anti-phospho-p38 and anti-actin. They were visualized with peroxidase-conjugated second antibodies using a standard ECL kit (Amersham, Inc., Arlington Heights, IL, U.S.A.). Table 1 , FTY720 exhibited comparatively low IC 50 values within the concentration range of 5-7 mM for all of the cells tested in this study. Judging from the values, the effects of sphingosine were two to three times lower than those of FTY720, except for the comparative effects on SW620 cells. We also tested an analog of FTY720, ISP-I-55, which lacks an aromatic ring in the aliphatic chain region. ISP-I-55 induced dose-dependent growth inhibition against breast cancer cell lines and colon cancer cell lines with IC 50 values comparable to those of sphingosine.
RESULTS
Inhibitory Effect of FTY720, Sphingosine and ISP-I-55 on Cancer Cell Proliferation
Effect of Sphingosine Kinase Inhibitor DMS on the Antiproliferative Activity of FTY720 It is known that FTY720 needs to be mono-phosphorylated by sphingosine kinase in the cytosol in order to become biologically active on sphingosine-1-P-receptors, S1P-R 1 and S1P-R 3 . 9) We used a potent inhibitor of sphingosine kinase, DMS, 16) to clarify the effects of the phosphorylation of FTY720 on the proliferation of a breast cancer cell line, MCF-7, on which S1P-R 1 and S1P-R 3 are highly expressed. 22) FTY720 in various concentrations with or without 10 mM DMS was treated with MCF-7 cells for 78 h and the cell viabilities were measured (Fig. 3) . The graph shows that the antiproliferative activity of FTY720 was enhanced rather than inhibited by co-treatment with DMS, suggesting that the endogenous phosphorylation of FTY720 is not required for its cytotoxicity. The increased activity may result from the increased amount of intact FTY720 resulting from the inhibition of its phosphorylation.
Effect of Phosphorylation of FTY720 on Cancer Cell Proliferation In order to investigate the effects of exogenous phosphorylated FTY720, we synthesized FTY720-P and a phosphatase-tolerant phosphinane FTY720 derivative, cFTY720-P. The IC 50 values of these agents against breast cancer cell lines (MCF-7, MDA-MB-231, Sk-Br-3) and colon cancer cell lines (HCT-116, SW620) were evaluated IC 50 values, the concentrations of tested compounds causing 50% growth inhibition in the WST-1 assay 48 h after treatment, were determined by linear interpolation between the values immediately above and below the 50% inhibition. Values are meansϮS.D. from at least three independent experiments. using a WST-1 assay (Table 2 ). Both compounds showed considerably high IC 50 values in comparison to FTY720. The low concentration range of FTY720-P induced cell growth slightly in MCF-7. This tendency was stronger for sphingosine-1-P, although this compound was more cytotoxic in a higher concentration range (Fig. 4) .
The Effect of FTY720 and Sphingosine on the Activation of Major MAPKs in MCF-7 Cells We evaluated the effect of FTY720 (10 mM) and sphingosine (20 mM) on the phosphorylation of major MAPKs, survival MAPK/extracellular signal-regulated kinase, ERK1/ERK2, the stress-activated MAPK c-Jun NH 2 -terminal kinase, JNK1/JNK2 and the death kinase p38 in a human breast cancer cell line, MCF-7. Treatment of MCF-7 cells with FTY720 for 0.5 h caused a strong down-regulation of phosphorylated ERK1/ ERK2 (p-ERK1/p-ERK2), whereas long term incubation caused a recovery of p-ERK1/p-ERK2 expression level. The phosphorylation of ERK was also inhibited by treatment of the cells with sphingosine for 0.5 h. On the other hand, the phosphorylation of JNK1/JNK2 was induced 2-8 h after the addition of FTY720 or sphingosine. Both FTY720 and sphingosine led to the activation of JNK1/JNK2, but not of p38 (Fig. 5) .
DISCUSSION
We evaluated the antiproliferative effects of FTY720, sphingosine and their analogues on human breast cancer cell lines MCF-7, MDA-MB-231, and Sk-Br-3 as well as human colorectal cancer cell lines HCT-116 and SW620. FTY720, sphingosine and ISP-I-55 inhibited the growth of these cells. FTY720 showed the highest cytotoxicity among the tested compounds. ISP-I-55 has a structure lacking a benzene ring found in FTY720. Judging from the mouse allogeneic mixed lymphocyte reaction, 17) the immunosuppressive effect of ISP-I-55 is less active than that of FTY720. A similar structureactivity relationship has been shown in the cytotoxicity between these two compounds. Western blot analysis of the cytosolic fraction of MCF-7 cells demonstrated that 10 mM FTY720 or 20 mM sphingosine temporally deactivated the phosphorylation of a survival MAPK, ERK, and activated the phosphorylation of death kinase, JNK without modulation of p-p38. The recovery of p-ERK expression after the temporal down-regulation would be associated with the regulation of apoptosis or survival signaling in the cells. 23, 24) The results suggested that the antiproliferation of FTY720 and sphingosine proceeded in a similar manner including the induction of apoptosis. Although FTY720-P and cFTY720-P are active mediators in the immunomodulation and endothelial cell functions, these compounds affected little to the cell growth. Observation of the low cytotoxicity of FTY720-P may be caused by endogenous dephosphorylation, since phosphatase-tolerant cFTY720-P has much less of an effect. Furthermore, the pretreatment of DMS did not inhibit the ef- Compounds with and without DMS (10 mM) were added to the wells and the plates were incubated for 78 h (37°C, 5% CO 2 ) before a WST-1 assay was conducted. Bars represent the S.D. of triplicate assays. fects of FTY720, but it increased the effect of FTY720. This may be caused by the increased amount of intact FTY720 resulting from the inhibition of the phosphorylation with an effect of DMS. The results indicate that neither the endogenous nor the exogenous phosphorylation of FTY720 is involved in the cytotoxicity of the compound.
